Bnp Paribas Legend Biotech Corp Transaction History
Bnp Paribas
- $1.99 Trillion
- Q2 2024
Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
198Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$555 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$363 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$320 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$276 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$230 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $8.08B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...